Navigation Links
CVBT Interim Board of Directors Remains In Place
Date:6/20/2013

LAS VEGAS, June 21, 2013 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (CVBT) announced today that the Delaware Court of Chancery ruled that Mickael A. Flaa, Grant Gordon, Calvin A. Wallen III, Jon Ross, and Robert Schleizer will remain in place as the CVBT Board of Directors pending resolution of the lawsuit filed on June 9, 2013, by Mickael A. Flaa in that Court.  The Delaware lawsuit seeks, among other things, to confirm the validity of the action by written consent of stockholders on June 7, 2013, to remove Daniel C. Montano, John (Jack) Jacobs, Ernest C. Montano, Viktoriya T. Montano, Ernest Montano III, and Joong Ki Baik as directors of CVBT.  Pending resolution of the Delaware lawsuit, or further order of the Delaware Court of Chancery, the power of CVBT's interim Board of Directors to take certain [extraordinary] actions on behalf of CVBT will be limited by a status quo order, which has not yet been entered.

About CardioVascular BioTherapeutics
CVBT is a biopharmaceutical company developing drug candidates with FGF-1 as its active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to tissue or organs. The company is the sponsor of a Phase II trial to treat severe coronary heart disease (CVBT-141H), and has received FDA authorization for a Phase I trial to treat peripheral arterial disease (CVBT-141C). A Late-Stage trial to treat chronic diabetic foot ulcers (CVBT-141B) is planned pending FDA approval.

Forward
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013
2. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
3. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
4. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
5. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
7. OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
8. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
9. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Golden Meditech Announces 2012 / 2013 Interim Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... , Industry professionals and ... Tweetchat taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of ... of its kind global industry-wide Tweetchat for pharma ... aimed to stimulate conversations on key industry issues ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Needle-Free Delivery: Technology ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report Details ... commercial prospects What does the future hold ... new report shows you the potential revenues ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... 2012 ConvaTec, a world-leading developer and marketer of ... announces that Ken Berger will assume the position of ... Board of Directors. Berger joins ConvaTec from ... years, most recently as Senior Vice President and Group ...
...  Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... , Citi 2012 Global Healthcare Conference at 3:00 p.m. ... RBC Capital Markets, Healthcare Conference at 9:00 a.m. Eastern ... sessions may be accessed through the Company,s web site, ...
Cached Medicine Technology:ConvaTec Announces the Appointment of Ken Berger to the Position of CEO Effective March 6, 2012 2Regeneron Announces February 2012 Investor Conference Presentations 2
(Date:8/30/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:8/30/2014)... Tulsa, OK (PRWEB) August 30, 2014 ... especially valuable, and increasingly difficult to get. Snoring and ... during sleep and breathing stops) robs people and their ... their daily challenges. Up to 45% of the population ... alone have sleep apnea. Of these, only 10% have ...
(Date:8/30/2014)... One of the most recent dietary trends to have ... meant for sufferers of gluten intolerance and celiac disease, the ... looking to get healthier by simply consuming foods which are ... information erroneous, it also exposes those same consumers to ... change in their food consumption habits. , Because ...
(Date:8/30/2014)... August 30, 2014 Top10BestSEOHosting.com is ... researchers have announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ... current market. Also, they has announced that Bluehost ... , Hostgator, one of the Top 10 ... of cheap Windows hosting, and it offers rich ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The new review ... program was created by Karen Brimeyer, who wanted to make ... , This guide is now easy to find in ... download. In this guide, the author of the new method ... , Daily Gossip writes in its review that the ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... Tube-Feeding Best-Practice Recommendations NEW ORLEANS, Feb. 3 ... HealthCare Nutrition and the American Society for Parenteral ... launch of a new initiative to promote safe ... designed to raise awareness of key steps that ...
... LEXINGTON, Ky., Feb. 3 Just because the economy isn,t ... a Valentine,s surprise for that,special someone. Now,s the time ... from discounted treatments to complimentary services. Roses wilt,and chocolates melt, ... not only a,romantic gift but a healthful one too. , ...
... out the bumps in aesthetic skin care with its latest offering. ... the UniForm handpiece, recently approved by the FDA for cellulite treatment. ... ... seeking painless cellulite treatment, New York City based Juva Skin and ...
... (February 2, 2009) New research published in the ... College of Surgeons suggests that a traditional, "open" ... for the majority of patients with acute appendicitis, contrary ... are performed in the United States each year to ...
... Feb. 2 Smith & Nephew,s Advanced Wound ... announced that the U.S. Court of Appeals for the Federal ... 1 negative pressure wound therapy system marketed by Blue Sky ... Sky in May 2007."Smith & Nephew welcomes the appeals court ...
... Living: The Financial Options Guide Now Available at Sunrise ... Senior Living (NYSE: SRZ ) now offers ... families identify ideas for affording senior care in today,s ... Living: The Financial Options , is available at Sunrise ...
Cached Medicine News:Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 2Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 3Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 4Health News:Rev Up the Romance this Valentine's Day with Savvy Spa Savings 2Health News:Juva Skin Banishes Bumps with New UniForm Cellulite Therapy Handpiece 2Health News:Treating appendicitis by laparoscopic surgery may not be worth the cost 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 3Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
... Micro Thin Sheet. Medpor Sheets are ... and other craniofacial applications. The thinner ... provide the surgeon with greater flexibility ... for easy insertion into the orbit. ...
Adjustable piston accommodates 7 - 9 mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9 mm trephine blades and 18 mm diameter Teflon block. Designed for accurate ...
Medicine Products: